P. Ruggenenti

Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes

P. Ruggenenti, Flavio Gaspari, Annalisa Perna et al. · BMJ · 1998 · 266 citations · Full text

SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA

Pantelis Sarafidis, Charles J. Ferro, Enrique Morales et al. · Nephrology Dialysis Transplantation · 2019 · 198 citations

Effect of low-dose enalapril on glomerular size-selectivity in human diabetic nephropathy

Andrea Remuzzi, P. Ruggenenti, Lidia Mosconi et al. · Aisberg (University of Bergamo) · 1993 · 67 citations

Renal Function, Glomerular Size-selectivity, Medicine +9

Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies

P. Ruggenenti, Annalisa Perna, Lidia Mosconi et al. · Kidney International · 1997 · 50 citations

Glomerular Disease, Glomerulonephritis, Urology +10

Continuum of renoprotection with Losartan at all stages of type 2 diabetic nephropathy: A post hoc analysis of the RENAAL trial results:A post hoc analysis of the RENAAL trial results

Giuseppe Remuzzi, P. Ruggenenti, Annalisa Perna et al. · University of Groningen research database (University of Groningen / Centre for Information Technology) · 2004 · 23 citations